Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma

被引:2
|
作者
Li, Shuaishuai [1 ]
Zhu, Jiawei [1 ]
He, Zhenwei [2 ]
Ashok, Raj [1 ]
Xue, Ning [1 ]
Liu, Zijie [1 ]
Ding, Li [1 ]
Zhu, Haitao [1 ]
机构
[1] Xuzhou Med Univ, Dept Urol, Affiliated Hosp, Xuzhou, Peoples R China
[2] Xuzhou Med Univ, Dept Neurosurg, Affiliated Hosp, Xuzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
chromophobe renal cell carcinoma; nomogram; SEER; prognosis; overall survival; cancer-specific survival; validation; PROGNOSTIC-FACTORS;
D O I
10.3389/fonc.2022.982833
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveThe purpose of our study is to construct and validate nomograms that effectively predict postoperative overall survival and cancer-specific survival for patients with chromophobe renal cell carcinoma (chRCC). MethodClinical, social, and pathological data from 6016 patients with chRCC collected from the SEER database were screened from 2004 to 2015. They were randomly assigned to a training cohort (n = 4212) and a validation cohort (n = 1804) at a 7:3 ratio. Cox regression and least absolute shrinkage and selection operator (LASSO) analyses were used to identify the prognostic factors affecting overall survival (OS) and cancer-specific survival (CSS) and establish nomograms. Their performance was validated internally and externally by calculating Harrell's C-indexes, area under the curve (AUC), calibration, and decision curves. For external validation, samples from postoperative patients with chRCC at 3 independent centers in Xuzhou, China, were collected. Risk stratification models were built according to the total scores of each patient. Kaplan-Meier curves were generated for the low-risk, intermediate-risk, and high-risk groups to evaluate survival. ResultsThe C-indexes, AUC curves, and decision curves revealed the high ability of the nomograms in predicting OS and CSS, overall better than that of AJCC and TNM staging. Moreover, in internal and external validation, the calibration curves of 5-, 8-, and 10-year OS agreed with the actual survival. Kaplan-Meier curves indicated significant differences in survival rates among the 3 risk groups in OS or CSS. ConclusionThe nomograms showed favourable predictive power for OS and CSS. Thus, they should contribute to evaluating the prognosis of patients with chRCC. Furthermore, the risk stratification models established on the nomograms can guide the prognosis of patients and further treatment.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Development and validation of nomograms for predicting survival in patients with non-metastatic colorectal cancer
    Jiang, Huihong
    Tang, Erjiang
    Xu, Dan
    Chen, Ying
    Zhang, Yong
    Tang, Min
    Xiao, Yihua
    Zhang, Zhiyong
    Deng, Xiaxing
    Li, Huaguang
    Lin, Moubin
    ONCOTARGET, 2017, 8 (18) : 29857 - 29864
  • [22] Predicting survival of patients with metastatic renal cell carcinoma
    R. J. Motzer
    M. Mazumdar
    Der Urologe, 2004, 43 : 135 - 136
  • [23] Predicting survival of patients with metastatic renal cell carcinoma
    Motzer, RJ
    Mazumdar, M
    UROLOGE A, 2004, 43 (Suppl 3): : S135 - S136
  • [24] Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma
    Song, Zhengqing
    Cheng, Lisha
    Lu, Lili
    Lu, Weiqi
    Zhou, Yuhong
    Wang, Zhiming
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [25] Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma
    Chen, Chunyang
    Geng, Xinyu
    Liang, Rui
    Zhang, Dongze
    Sun, Meiyun
    Zhang, Guangbo
    Hou, Jianquan
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (06) : 729 - 739
  • [26] Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular Carcinoma
    He, Yongzhu
    Luo, Laihui
    Shan, Renfeng
    Qian, Junlin
    Cui, Lifeng
    Wu, Zhao
    Tu, Shuju
    Zhang, Wenjian
    Lin, Wei
    Tang, Hongtao
    Huang, Zeyu
    Li, Zhigang
    Mao, Shengping
    Li, Hui
    Hu, Zemin
    Liu, Liping
    Shen, Wei
    He, Kun
    Li, Yong
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (1D):
  • [27] Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer
    Xiao, Hai-Fan
    Zhang, Bai-Hua
    Liao, Xian-Zhen
    Yan, Shi-Peng
    Zhu, Song-Lin
    Zhou, Feng
    Zhou, Yi-Kai
    ONCOTARGET, 2017, 8 (38) : 64303 - 64316
  • [28] Development and validation of prognostic nomograms for adult with papillary renal cell carcinoma: A retrospective study
    Guo, Qingxiang
    Li, Sai
    Zhu, Jiawei
    Wang, Zewei
    Li, Zhen
    Wang, Junqi
    Wen, Rumin
    Li, Hailong
    CLINICS, 2024, 79
  • [29] Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma
    Sun, Xuqi
    Wang, Yangyang
    Ge, Hongbin
    Chen, Cao
    Han, Xu
    Sun, Ke
    Wang, Meng
    Wei, Xiaobao
    Ye, Mao
    Zhang, Qi
    Liang, Tingbo
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1181 - 1194
  • [30] Understanding m6A changes in chromophobe renal cell carcinoma and predicting patient outcomes survival
    Chen, Zhigang
    Yang, Junbo
    Zhang, Wei
    Qian, Yang
    Zhang, Nan
    Chen, Zixin
    Lu, Min
    Ge, Liyuan
    Liu, Cheng
    Tian, Xiaojun
    Jia, Guifang
    Ma, Lulin
    Li, Baoguo
    BMC CANCER, 2024, 24 (01)